• Sanofi revenue by segment 2014-2021

In 2021, the French pharmaceutical and healthcare company by the name of Sanofi generated approximately 27 billion U.S. dollars through its pharmaceuticals segment. Sanofi’s relatively new consumer healthcare segment earned the company about 4.5 billion U.S. dollars in that year.

Sanofi’s top products

Sanofi develops various pharmaceutical products, including Aubagio, Lovenox, and Dupixent. One of the company’s top products based on revenue is also Lantus. In 2021, this long-acting insulin used to treat diabetes, generated some 2.5 billion U.S. dollars. Aubagio earned the company roughly two billion U.S. dollars within the same year.

Top U.S. drugs

Based on sales numbers over the last years, Humira is by far the top prescription drug in the United States. The drug generates over 20 billion U.S. dollars in the United States per year. Among the country’s most prescribed medicines, however, are Atorvastatin, Lisinopril, and Levothyroxine.

Revenue of Sanofi by segment from 2014 to 2021 (in million euros)

Characteristic	Pharmaceuticals	Vaccines	Consumer Healthcare*	Animal Health*
-	-	-	-	-
-	-	-	-	-
-	-	-	-	-
-	-	-	-	-
-	-	-	-	-
-	-	-	-	-
-	-	-	-	-
-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2022

More information

Region

Worldwide

Survey time period

2014 to 2021

Supplementary notes

* During 2016, the Animal Health and the Consumer Healthcare segments were the objects of a swap deal between Sanofi and Boehringer Ingelheim. Since 2016, Animal Health revenues were no longer part of Sanofi's total revenues.